UPDATE: Piper Sandler Starts Sight Sciences Inc. (SGHT) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BofA Securities Starts Sight Sciences Inc. (SGHT) at Buy
August 9, 2021 8:53 AM EDTBofA Securities analyst Bob Hopkins initiates coverage on Sight Sciences Inc. (NASDAQ: SGHT) with a Buy rating and a price target of $45.00.
The analyst comments "We are initiating coverage of Sight Sciences (SGHT), a company with innovative medical devices to treat glaucoma and dry eye disease with a Buy rating and $45 price objective.... More
UPDATE: Morgan Stanley Starts Sight Sciences Inc. (SGHT) at Equalweight
August 9, 2021 4:21 AM EDT(Updated - August 9, 2021 5:11 AM EDT)
Morgan Stanley analyst Cecilia Furlong initiates coverage on Sight Sciences Inc. (NASDAQ: SGHT) with a Equalweight rating and a price target of $41.00.
The analyst comments "We think share gains and material market growth and expansion support a... More
